These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35959923)

  • 1. Identification of a Novel Pseudo-Natural Product Type IV IDO1 Inhibitor Chemotype.
    Davies C; Dötsch L; Ciulla MG; Hennes E; Yoshida K; Gasper R; Scheel R; Sievers S; Strohmann C; Kumar K; Ziegler S; Waldmann H
    Angew Chem Int Ed Engl; 2022 Oct; 61(40):e202209374. PubMed ID: 35959923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
    Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
    Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Based Identification of New IDO1 Modulator Chemotypes.
    Hennes E; Lampe P; Dötsch L; Bruning N; Pulvermacher LM; Sievers S; Ziegler S; Waldmann H
    Angew Chem Int Ed Engl; 2021 Apr; 60(18):9869-9874. PubMed ID: 33565680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unprecedented Combination of Polyketide Natural Product Fragments Identifies the New Hedgehog Signaling Pathway Inhibitor Grismonone.
    Grigalunas M; Patil S; Krzyzanowski A; Pahl A; Flegel J; Schölermann B; Xie J; Sievers S; Ziegler S; Waldmann H
    Chemistry; 2022 Dec; 28(67):e202202164. PubMed ID: 36083197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of immunosuppressive indoleamine 2,3-dioxygenase by targeting the heme and apo-form.
    Pradhan N; Akhtar N; Nath B; Peña-García J; Gupta A; Pérez-Sánchez H; Kumar S; Manna D
    Chem Commun (Camb); 2021 Jan; 57(3):395-398. PubMed ID: 33326535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*.
    Ortiz-Meoz RF; Wang L; Matico R; Rutkowska-Klute A; De la Rosa M; Bedard S; Midgett R; Strohmer K; Thomson D; Zhang C; Mebrahtu M; Guss J; Totoritis R; Consler T; Campobasso N; Taylor D; Lewis T; Weaver K; Muelbaier M; Seal J; Dunham R; Kazmierski W; Favre D; Bergamini G; Shewchuk L; Rendina A; Zhang G
    Chembiochem; 2021 Feb; 22(3):516-522. PubMed ID: 32974990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors.
    Singh R; Salunke DB
    Eur J Med Chem; 2021 Feb; 211():113071. PubMed ID: 33341650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3.
    Karageorgis G; Reckzeh ES; Ceballos J; Schwalfenberg M; Sievers S; Ostermann C; Pahl A; Ziegler S; Waldmann H
    Nat Chem; 2018 Nov; 10(11):1103-1111. PubMed ID: 30202104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel IDO1 inhibitors targeting the protein's apo form through scaffold hopping from holo-IDO1 inhibitor.
    Wu Y; Duan Q; Zou Y; Zhu Q; Xu Y
    Bioorg Med Chem Lett; 2021 Nov; 52():128373. PubMed ID: 34560264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.
    Nelp MT; Kates PA; Hunt JT; Newitt JA; Balog A; Maley D; Zhu X; Abell L; Allentoff A; Borzilleri R; Lewis HA; Lin Z; Seitz SP; Yan C; Groves JT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3249-3254. PubMed ID: 29531094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.
    Cui G; Lai F; Wang X; Chen X; Xu B
    Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the discovery and development of selective heme-displacing IDO1 inhibitors.
    Sun L
    Expert Opin Drug Discov; 2020 Oct; 15(10):1223-1232. PubMed ID: 32568559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1.
    Markwalder JA; Balog AJ; Williams DK; Nara SJ; Reddy R; Roy S; Kanyaboina Y; Li X; Johnston K; Fan Y; Lewis H; Marsilio F; Yan C; Critton D; Newitt JA; Traeger SC; Wu DR; Jure-Kunkel MN; Jayaraman L; Lin TA; Sinz MW; Hunt JT; Seitz SP
    Bioorg Med Chem Lett; 2023 May; 88():129280. PubMed ID: 37054759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity.
    Tsujino H; Uno T; Yamashita T; Katsuda M; Takada K; Saiki T; Maeda S; Takagi A; Masuda S; Kawano Y; Meguro K; Akai S
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126607. PubMed ID: 31431359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Indofulvin Pseudo-Natural Products Yields a New Autophagy Inhibitor Chemotype.
    Burhop A; Bag S; Grigalunas M; Woitalla S; Bodenbinder P; Brieger L; Strohmann C; Pahl A; Sievers S; Waldmann H
    Adv Sci (Weinh); 2021 Oct; 8(19):e2102042. PubMed ID: 34346568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Biological Evaluation of Chemically and Biologically Diverse Pyrroquinoline Pseudo Natural Products.
    Liu J; Cremosnik GS; Otte F; Pahl A; Sievers S; Strohmann C; Waldmann H
    Angew Chem Int Ed Engl; 2021 Feb; 60(9):4648-4656. PubMed ID: 33200868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
    Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.
    Peng YH; Ueng SH; Tseng CT; Hung MS; Song JS; Wu JS; Liao FY; Fan YS; Wu MH; Hsiao WC; Hsueh CC; Lin SY; Cheng CY; Tu CH; Lee LC; Cheng MF; Shia KS; Shih C; Wu SY
    J Med Chem; 2016 Jan; 59(1):282-93. PubMed ID: 26642377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Röhrig UF; Majjigapu SR; Vogel P; Reynaud A; Pojer F; Dilek N; Reichenbach P; Ascenção K; Irving M; Coukos G; Michielin O; Zoete V
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1773-1811. PubMed ID: 35758198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.